Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

09/09/03 Survivin in brain tumors: an attractive target for immunotherapy.        

09/09/03 Autologous adjuvant linked fibroblasts induce anti-glioma immunity: implications for development of a glioma vaccine.        

09/09/03 Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma.        

09/09/03 Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma.        

09/09/03 Treatment with allogeneic interleukin-2 secreting fibroblasts protects against the development of malignant brain tumors.        

09/09/03 Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene--a phase I/II clinical protocol.        

09/09/03 Gene therapy for experimental brain tumors using a xenogenic cell line engineered to secrete hIL-2.        

09/09/03 The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors.        

09/09/03 Human autologous dendritic cell-glioma fusions: feasibility and capacity to stimulate T cells with proliferative and cytolytic activity.        

09/09/03 Brain tumor immunotherapy: an immunologist's perspective.        

09/09/03 Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression.        

09/03/03 Safety of multiple stereotactic radiosurgery treatments for multiple brain lesions.        

09/03/03 Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide.        

09/03/03 Dr. Susan Pannullo, Director of Neuro-Oncology at New York Presbyterian Hospital Weill Cornell Medical Center, will be the guest speaker at the Long Island (NY) Adult Brain Tumor Support Group tommorrow, Thursday Sept 4, at 7pm.        

09/03/03 Role of early radiotherapy in the treatment of supratentorial WHO Grade II astrocytomas: long-term results of 97 patients.        

09/03/03 Better imaging targets tumors
Advancement has potential to help improve brain cancer patients’ prognosis        

09/02/03 Long-Term Neurologic and Neurosensory Sequelae in Adult Survivors of a Childhood Brain Tumor: Childhood Cancer Survivor Study        

08/30/03 Neuro-Oncology Working Group 01 Trial of Nimustine Plus Teniposide Versus Nimustine Plus Cytarabine Chemotherapy in Addition to Involved-Field Radiotherapy in the First-Line Treatment of Malignant Glioma        

08/26/03 An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.        

---

Displaying Stories 5710 to 5729 of 7812
Previous 20           Next 20